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Abstract In this study we demonstrate the existence of a 
protein with properties of the voltage-dependent anion channel 
(VDAC) in the sarcoplasmic reticulum (SR) using multiple 
approaches as summarized in the following: (a) 35 and 30 kDa 
proteins in different SR preparations, purified from other 
membranal systems by Ca2+loxalate loading and sedimentation 
through 55% sucrose, cross-react with four different VDAC 
monoclonal antibodies. (b) Amino acid sequences of three 
peptides derived from the SR 35 kDa protein are identical to 
the sequences present in VDACI isoform. (c) Similar to the 
mitochondrial VDAC, the SR protein is specifically labeled by 
[14C]DCCD. (d) Using a new method, a 35 kDa protein has been 
purified from SR and mitochondria with a higher yield for the 
SR. (e) Upon reconstitution into a planar lipid bilayer, the 
purified SR protein shows voltage-dependent channel activity 
with properties similar to those of the purified mitochondrial 
VDAC or VDACllporin 31HL from human B lymphocytes, and 
its channel activity is completely inhibited by the anion transport 
inhibitor DIDS and about 80% by DCCD. We also demonstrate 
the translocation of ATP into the SR lumen and the 
phosphorylation of the luminal protein sarcalumenin by this 
ATP. Both ATP translocation and sarcalumenin phosphoryla- 
tion are inhibited by DIDS, but not by atractyloside, a blocker of 
the ATPIADP exchanger. These results indicate the existence of 
VDAC, thought to be located exclusively in mitochondria, in the 
SR of skeletal muscle, and its possible involvement in ATP 
transport. Together with recent studies on VDAC multi- 
compartment location and its dynamic association with enzymes 
and channels, our findings suggest hat VDAC deserves attention 
and consideration as a protein contributing to various cellular 
functions. 
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ATP transporters: carriers and channels, e.g. the mitochon- 
drial inner membrane ADP/ATP  exchanger and the outer 
membrane pore-forming protein VDAC, referred to as mito- 
chondrial porin. 
VDAC is an abundant protein (30-35 kDa) found in all 
eukaryotes [7-9]. When reconstituted into a planar lipid bi- 
layer, VDAC forms a large ( ,~3 nm) voltage-gated pore, 
that can exist in multiple conformational states with variable 
conductivity and selectivity towards anions and cations ac- 
cording to its opening state [7,9,10]. VDAC is thought to 
function as the primary pathway for movement of  adenine 
nucleotides [7]. The molecular nature of the VDAC gating 
mechanism has yet to be resolved. Accumulating evidence 
points to a complex regulation of VDAC permeability [11]. 
Until recently VDAC was thought to be located exclusively 
in the outer mitochondrial membrane. More recently, how- 
ever, different studies have demonstrated the expression of 
mammalian VDAC in different cell compartments other 
than mitochondria [12-16]. Multiple human porin isoforms 
have been demonstrated and interpreted as an indication for 
a variety of functions [17]. Furthermore, VDAC has been 
shown to be associated with different proteins such as hexo- 
kinase, creatine and glycerol kinases, benzodiazepine r ceptor, 
adenine nucleotide translocator, the outwardly rectifying de- 
polarization-induced chloride channel (ORDIC) [16,18]. This 
association is dynamic, constitutes a regulatory interaction 
and may be involved in several diseases [16,18]. 
Here we demonstrate the presence of VDAC in the SR of 
skeletal muscle, and its possible involvement in ATP transport 
into the SR lumen. 
2. Materials and methods 
I. Introduction 
SR is a subcellular organelle responsible for regulating the 
Ca 2+ concentration i  the cytosol of the muscle fibers by an 
ATP-powered Ca 2+ pump and by the Ca 2+ release channel/ 
ryanodine receptor [1-3]. Phosphorylation of the SR luminal 
proteins, sarcalumenin, calsequestrin and histidine-rich Ca 2+ 
binding protein (HCP), requires ATP transport into the SR 
lumen [4-6]. Mammalian cells have two principle types of 
2.1. Membrane preparations 
SR membranes were prepared from rabbit skeletal muscle using 
differing methods [19-21]. SR vesicles were actively loaded with 
Ca2+/oxalate and purified by sedimentation through 55% sucrose. 
The reaction mixture for loading (total volume 30 ml) contained 20 
mM Mops, pH 6.8, 100 mM NaCI, 3 mM MgC12, 2mM ATP, 0.5 
mM EGTA, 10 mM Na/oxalate and 0.4 mg/ml SR membranes. Ca 2+ 
uptake was initiated by two additions of CaC12 to a final concentra- 
tion of 0.5 mM at 10 rain intervals. After 20 min at 30°C the sample 
was layered on top of 55% sucrose (8 ml) and centrifuged for 2 h at 
100000×g. The pellet was suspended in a solution containing 0.25 M 
sucrose and 10 mM Tricine, pH 7.4. Mitochondria were isolated as 
described previously [22]. Protein concentration was determined by 
the method of Lowry et al. [23]. 
*Corresponding author. Fax: (972) (7) 472992. 
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dent anion channel; DIDS, 4,4'-diisothiocyanostilbene 2,2'-disulfonic 
acid; DCCD, dicyclohexylcarbodiimide; Tricine, N-[2-hydroxy-l,1- 
bis-(hydroxymethyl)ethyl]glycine 
2.2. ATP transport 
Unloaded- and Ca2+/oxalate-loaded SR vesicles (1 mg/ml) were 
assayed for ATP transport by incubation for lmin at 30°C in a solu- 
tion containing 0.1 M NaCI and 20 mM Tricine, pH 7.2 (Buffer A) 
and the indicated concentrations of [ct-32p]ATP (106 cprn/nmol). The 
membranes were filtered (0.3 Ixm) and immediately washed with 3 X 4 
ml of buffer A containing 0.1 mM ATP. 
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2.3. VDAC purification 
SR (15 mg) was solubilized (at 2 mg/ml) for 20 min at 0°C with 
Nonidet P-40 (NP-40) (1.3%) in 10 mM Tris-HC1, pH 7.2, containing 
0.15 mM PMSF and 0.5 Ixg/ml eupeptin. The NP-40 extract was 
loaded onto a spermine-agarose column (1 ×4 cm) pre-equilibrated 
with 0.4% NP-40 and 10 mM Tris-HC1, pH 7.2 (buffer N). The 
pass-through was applied to a CM-cellulose (1.2×4 cm) pre-equili- 
brated with buffer N. VDAC was eluted with buffer N containing 50 
mM NaCI. 
2.4. Single channel reconstitution and analysis 
Channel reconstitution, recording and analysis were carried out as 
described previously [24] and in the legend to Fig. 4. 
3. Results and discussion 
Fig. 1 shows the transport of [c~-32P]ATP into the SR lumen 
and the phosphorylation of the luminal SR, sarcalumenin. 
The transport of ATP is increased with increasing ATP con- 
centration, where the double reciprocal plot yield non-linear 
line, inconsistent with carrier-mediated transport. Further 
purification of SR vesicles from other membrane impurities, 
by ATP-dependent Ca2+/oxalate-loading and sedimentation 
through 55% sucrose, results in vesicles with a greater than 
2-fold increase in specific ATP accumulation (Fig. 1A), sug- 
gesting a richer selection of purified, intact SR vesicles. Ana- 
lysis of the transported [c¢-32P]-labeled nucleotides revealed 
that it comprises about 80% [ct-32p]ATP and 20% [a- 
32p]ADP. 
The [a-azp]ATP translocation is inhibited by 4,4'-diisothio- 
cyanostilbene 2,2'-disulfonic acid (DIDS), an anion transport 
inhibitor [25], and by dicyclohexylcarbodiimide (DCCD) but 
not by atractyloside, a specific ATP /ADP exchanger inhibitor 
[26] (Fig. 1B,C). These compounds also inhibited the trans- 
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Fig. 1. ATP is transported into the SR vesicles and phosphorylates luminal proteins. (A) Unloaded (o) and Ca2+/oxalate-loaded (©)SR (2 mg/ 
ml) were assayed for ATP transport for 1 min in 0.1 M NaC1 and 20 mM Tricine, pH 7.2 (buffer A), at various concentrations of [c~-32p]ATP. 
(B) SR was incubated for 10 min at 30°C without or with DIDS in buffer A. (C) SR was modified with DCCD for 15 min at 24°C in 20 mM 
Mes, pH 6.1, and 0.1 M NaC1, or with atractyloside in buffer A. ATP transport was assayed as described in Section 2 in buffer A containing 
0.3 mM [ct-32p]ATP (B,C). Control activity (100%)=1.7, 0.48, and 0.31 nmol/mg/min for A, B, and C, respectively. (D) Unmodified and DIDS- 
modified SR were endogenously phosphorylated by [y-z2P]ATP, subjected to SDS-PAGE (7% acrylamide), Coomassie staining, and to autora- 
diography or Western blot analysis, using monoclonal anti-sarcalumenin/anti-53 kDa glycoprotein antibody (G10). The phosphorylation of 
Ca2+-ATPase in the presence of DIDS results from DIDS inhibition of its activity [47], and stabilizing it at the phosphorylated state. CBB 
shows Coomassie blue staining of a representative lane. CS, calsequestrin; RyR, ryanodine receptor. SR membranes were prepared as described 
in [20] and was actively loaded with Ca2+/oxalate and purified by sedimentation through 55% sucrose as described in section 2. 
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Fig. 2. Identification and purification of a 35kDa SR protein as VDAC. In A, SDS-PAGE (615% acrylamide) patterns of different SR pre- 
parations isolated according to Saito et al. [21] (A), MacLennan [22] (B) or Lai et al. [23] (C), before and after Ca2+/oxalate loading, and their 
corresponding immunoblot staining using monoclonal antibodies to human porin 31HL (1:5000, Calbiochem), are presented. In B, VDAC is 
purified from SR using two step chromatography, as described under section 2. SDS-PAGE pattern of the indicated fractions and their corre- 
sponding immunoblot are shown. The arrows in B point to the 35 kDa protein and to the antibody cross-reacted band. 
port of [c(-32P]ATP in Ca2+/oxalate-loaded purified SR vesi- 
cles (not shown). 
The presence of an ATP transport system in SR is also 
reflected in the endogenous phosphorylation of the luminal 
SR proteins, sarcalumenin and HCP (150 and 160 kDa), by 
the exogenous [y-3zp]ATP (Fig. 1D). DIDS and DCCD, which 
inhibited ATP transport (Fig. 1B,C), also inhibited the phos- 
phorylation of sarcalumenin a d HCP (Fig. 1D and [27]). The 
lack of inhibition of ATP transport by atractyloside rules out 
involvement of the mitochondrial ADP/ATP exchanger. Thus, 
ATP transport into the SR lumen may be mediated by a 
porin/VDAC-like protein, since VDAC channels are known 
to function in the movement of multiple negatively charged 
molecules uch as ATP and ADP [7,28]. 
The presence of a VDAC-like protein in different SR pre- 
parations is demonstrated in Fig. 2. Monoclonal antibodies, 
raised against he N-terminal part of the human B-lympho- 
cytes VDAC [29], cross-react with two SR proteins of 35 and 
30 kDa. We detected the two immunoreactive polypeptides of
35 and 30 kDa in SR in a ratio of about 10:1, while a much 
higher ratio is found in mitochondrial membranes (Fig. 2). 
The 30 kDa protein band is most probably not a proteolytic 
fragment since in the preparation of SR or mitochondria 
membranes we used five different protease inhibitors. More- 
over, as reported previously for the mitochondrial VDAC 
[30], the SR protein has very high resistance to proteases. 
No degradation of either 35 and 30 kDa proteins was ob- 
tained by exposure to trypsin or Staphylococcus aureus (Vs) 
at very high ratios (1:10 w/w; protease:SR) for up to 2 h, 
conditions in which most of the SR proteins were degraded 
(data not shown). Thus, these two immunoreactive polypep- 
tides represent two isoforms of VDAC. Indeed, the porin 
cDNA is translated in vitro to two protein species of about 
32 and 36 kDa [17]. 
Mitochondrial contamination is ruled out since: (a) SR 
vesicles, purified from other membrane impurities by ATP- 
dependent Ca2+/oxalate-loading, contain the two immuno- 
reactive proteins (Fig. 2); (b) both immunoreactive polypep- 
tides are detected in SR membranes prepared by different 
methods; (c) the specific activity in SR preparations of the 
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Fig. 3. [14C]DCCD labeling of the SR VDAC. In A, SR (1.2 mg/ml) in 50 ~1 of 20 mM Mes, pH 6.4, and 0.1 M NaC1 was incubated for 20 
min at 24°C with 10 ~tM [14C]DCCD, in the absence or presence of 0.2 mM DCCD, subjected to SDS-PAGE ((~16% acrylamide), Coomassie 
staining and fluorography. In B, [14C]DCCD-labeled VDAC was purified by spermine-agarose and CM-cellulose columns and analyzed by 
SDS-PAGE, autoradiography and immunostaining as in Fig. 2B. Void Fr. col. I and col. II indicate the pass through of the spermine-agarose 
and CM-cellulose columns, respectively. 
antimycin-insensitive NADH-cytochrome c reductase, a mito- 
chondrial outer membrane marker, was only 1% of that in 
isolated liver mitochondria; (d) the two 'isoforms' 30 and 35 
kDa are present in SR and mitochondrial membranes in a 
different ratio. 
A possible contamination of our SR preparations by trans- 
verse (T-) tubule membranes was tested by measuring the 
binding of dihydrophyridine ([3H]PN200-110). No measurable 
binding was obtained in the Ca2+/oxalate-loaded SR vesicles, 
and in other sucrose gradient-purified SR preparations, the 
activity was less than 1% of that of triads (terminal cister- 
nae/transverse tubule membranes) isolated as described pre- 
viously [31]. This is in agreement with the immunostaining 
studies of the SR in amphibian-skinned muscle fibers where 
no labeling was found on T-tubules [15]. It should be noted 
that Ca 2+ uptake by sarcolemmal vesicles is not stimulated by 
oxalate [32]. 
Identification of the 35 kDa immunoreactive SR protein as 
a VDAC is confirmed by amino acid sequences of three tryp- 
tic fragments (13, 21 and 7 amino acid long) derived from the 
purified protein and sequenced as described previously [33,34]. 
These sequences are found in the published amino acid se- 
quences of the VDAC1 isoform from bovine brain and of 
VDAC1/porin 31HL from human B lymphocytes [16]. 
Using a new method developed in our laboratory, SR 
35kDa protein was purified from Ca2+/oxalate-loaded v sicles 
and identified as VDAC (Fig. 2B). 
NP-40 solubilized SR proteins were loaded onto a sper- 
mine-agarose column on which about 98% of the total protein 
applied was adsorbed onto the column matrix, but not the 
basic protein VDAC. The porin-enriched fraction was further 
purified on carboxymethyl (CM) cellulose column from which 
homogeneous porin was eluted with NaC1. The protein pro- 
files of the various fractions and the corresponding immuno- 
blot are presented in Fig. 2B. VDAC was also isolated from 
rat liver mitochondria by the same procedure, and was used in 
reconstitution experiments for comparison. 
[14C]DCCD, at very low concentrations (1.5 nmol/mg pro- 
tein), was found to label mitochondrial VDAC by binding to 
a glutamate residue located at position 72 [35]. The 
[14C]DCCD specific labeling of the 35 kDa SR protein is 
demonstrated in Fig. 3. Unlabeled DCCD completely pre- 
vented the labeling of the 35 kDa protein, but not of other 
proteins. The [laC]DCCD-labeled SR protein, that was puri- 
fled by the procedure described in Fig. 2B, was found to 
cross-react with the anti-VDAC antibody (Fig. 3B). 
To further verify that the purified protein is indeed VDAC, 
the 35 kDa protein was reconstituted into planar lipid bilayer 
(PLB). The reconstituted 35 kDa protein shows voltage-de- 
pendent opening similar to that of the mitochondrial protein 
(Fig. 4). The fully open high-conductance state occurs in a 
voltage range from -15  to +15 mV (Fig. 4A). Like reconsti- 
tuted mitochondrial VDAC or VDAC1 (the plasma mem- 
brane 31HL porin) [7,9,10,16], the SR channel does not close 
completely. Inactivation of the reconstituted SR channel by 
DIDS and DCCD is demonstrated in Fig. 4B and C. DIDS 
completely closed the channel in a time-dependent manner via 
several intermediate conducting states. DIDS has been shown 
to alter the VDAC1 channel properties [36], and this protein 
was purified by DIDS affinity chromatography [37]. DCCD 
decreases the channel activity in a time-dependent manner via 
several intermediate conducting states to a final stable lower 
conducting state, but does not close the channel completely 
(Fig. 4C). The experiments reported here lead us to conclude 
that SR membranes contain a VDAC/porin, and that this 
protein is most likely involved in ATP transport into the SR 
lumen. 
The presence of a VDAC in SR is supported by the follow- 
ing: (i) A 35 kDa SR protein cross-reacts with four different 
VDAC monoclonal antibodies. (ii) Amino acid sequences of 
three peptides derived from the SR 35 kDa protein are iden- 
tical to the sequences present in VDAC1 isoform [16]. (iii) 
Similar to the mitochondrial VDAC, the SR protein is speci- 
fically labeled by [14C]DCCD. (iv) As expected for VDAC 
protein, an ATP transport activity is present in purified SR 
vesicles, and this activity is inhibited by DCCD and DIDS, 
which have been shown to interact specifically with VDAC 
([35-37], and Fig. 4). (v) Upon reconstitution i to a PLB, 
the purified SR VDAC shows voltage-dependent channel ac- 
tivity with properties imilar to those of the mitochondrial 
protein. 
These multiple approaches strongly indicate the existence of 
VDAC in skeletal muscle SR. The high permeability of the SR 
to monovalent cations and anions suggests the existence of 
cation and anion channels in the SR [1,38]. The proposed 
role of these channels is to minimize osmotic and potential 
changes during Ca 2+ transport and release, and to permit an 
exchange of metabolic intermediates between the SR lumen 
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Fig. 4. Channel activity of the purified SR VDAC reconstituted into a planar lipid bilayer and its modification by DIDS and DCCD. In (A), 
the voltage dependence of VDAC, isolated from rat liver mitochondria (©) and SR ( z~ ) (see Fig. 2B), reconstituted into PLB is presented. The 
ratio of the conductance (G/Go) (n=10), represents he conductance (G) at a given voltage, divided by the conductance at 10 mV (Go). The ef- 
fects of DIDS and DCCD modification on the SR channel activity are shown in (B) (single channel, at holding potential of -15 mV) and (C) 
(3 channels, at holding potential of -10 mV). Channel reconstitution, recording and analysis were carried out as described previously [23]. 
Purified protein (0.01-1 pg), DIDS or DCCD were added to the cis chamber to which the voltage was applied. The solutions used were 1 M 
NaCI, and either 10 mM CaC12, 10 mM Hepes, pH 7.4 for (A,B), or 10 mM Mes, pH 6.4 for (C). 
and the cytoplasm [1]. The VDAC channel could account for 
these functions and for the high anion permeability of the SR 
[39]. 
Recently, VDACs were shown to be located in different cell 
compartments other than mitochondria [12-16]. Immunolabel- 
ing for VDAC has demonstrated its existence on SR from 
amphibian skeletal muscle [15]. More recently [40], using im- 
munogold electron microscopy, VDAC1 was localized in SR 
of striated muscle fiber. 
VDAC reconstituted into PLB was not observed to close 
completely, even at non-physiological voltages ([7,9,10], and 
Fig. 4A). Our finding that DIDS completely closes the chan- 
nel is the first indication that the VDAC can indeed close 
completely. If this channel is present in SR, its large open- 
conductance and permeability to both anions and cations 
would provide a significant route for Ca 2+ leak from the 
SR. Yet, Ca 2+ accumulates in the SR and is released only 
in response to nerve stimulus. This may suggest hat like the 
paramecium itochondrial VDAC [41], the SR VDAC is also 
impermeable to Ca 2+. It is tempting, however, to speculate 
that the gating of the VDAC in SR is modulated by cellular 
components or processes, as previously demonstrated for the 
gating of the mitochondrial protein [18,42,43]. There is, as yet, 
no evidence of VDAC localization in the endoplasmic reticu- 
lum. However, ATP transport systems in vesicles derived from 
the yeast endoplasmic reticulum [44] or liver rough endoplas- 
mic reticulum [45] have been characterized, and it has been 
shown as well that Golgi complex is permeable to ATP which 
phosphorylated several intraluminal proteins [46]. 
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